TR200100769T2 - Yeni bir bileşim - Google Patents

Yeni bir bileşim

Info

Publication number
TR200100769T2
TR200100769T2 TR2001/00769T TR200100769T TR200100769T2 TR 200100769 T2 TR200100769 T2 TR 200100769T2 TR 2001/00769 T TR2001/00769 T TR 2001/00769T TR 200100769 T TR200100769 T TR 200100769T TR 200100769 T2 TR200100769 T2 TR 200100769T2
Authority
TR
Turkey
Prior art keywords
composition
compound component
mood disorders
new composition
disorders
Prior art date
Application number
TR2001/00769T
Other languages
English (en)
Turkish (tr)
Inventor
Evenden John
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200100769T2 publication Critical patent/TR200100769T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/00769T 1998-09-16 1999-09-13 Yeni bir bileşim TR200100769T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
TR200100769T2 true TR200100769T2 (tr) 2001-11-21

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00769T TR200100769T2 (tr) 1998-09-16 1999-09-13 Yeni bir bileşim

Country Status (21)

Country Link
EP (1) EP1121119A1 (ko)
JP (1) JP2002524509A (ko)
KR (1) KR20010099648A (ko)
CN (1) CN1317963A (ko)
AR (1) AR023657A1 (ko)
AU (1) AU6378199A (ko)
BR (1) BR9913765A (ko)
CA (1) CA2342585A1 (ko)
CZ (1) CZ2001962A3 (ko)
EE (1) EE200100156A (ko)
HU (1) HUP0103569A3 (ko)
ID (1) ID28359A (ko)
IL (1) IL141520A0 (ko)
IS (1) IS5877A (ko)
NO (1) NO20011313L (ko)
PL (1) PL346769A1 (ko)
SE (1) SE9803157D0 (ko)
SK (1) SK3272001A3 (ko)
TR (1) TR200100769T2 (ko)
WO (1) WO2000015219A1 (ko)
ZA (1) ZA200101951B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
WO2006123243A2 (en) 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
KR20010099648A (ko) 2001-11-09
EE200100156A (et) 2002-08-15
HUP0103569A3 (en) 2002-03-28
SE9803157D0 (sv) 1998-09-16
PL346769A1 (en) 2002-02-25
IS5877A (is) 2001-03-05
CN1317963A (zh) 2001-10-17
AU6378199A (en) 2000-04-03
JP2002524509A (ja) 2002-08-06
ZA200101951B (en) 2002-06-10
NO20011313L (no) 2001-05-16
NO20011313D0 (no) 2001-03-15
ID28359A (id) 2001-05-17
HUP0103569A2 (hu) 2002-02-28
BR9913765A (pt) 2001-06-05
CA2342585A1 (en) 2000-03-23
AR023657A1 (es) 2002-09-04
IL141520A0 (en) 2002-03-10
WO2000015219A1 (en) 2000-03-23
EP1121119A1 (en) 2001-08-08
CZ2001962A3 (cs) 2001-08-15
SK3272001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
ATE496884T1 (de) Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
SE0101675D0 (sv) Novel composition
YU40701A (sh) Piperidini kao modulatori ccr5
RS50814B (sr) Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
NO20042964L (no) Spiroazasykliske forbindelser som monoaminreseptormodulatorer
ATE380187T1 (de) Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
NO20042844L (no) 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister
TR200403020T2 (tr) (S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşim
ATE479655T1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
DK1461318T3 (da) Tetrahydroquinolinanaloge som muscariniske agonister
BR0306980A (pt) Composto, uso de um composto, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com o receptor de histamina h3
SE0403171D0 (sv) New compounds
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
PT1140031E (pt) Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa
SE0102055D0 (sv) New Compounds
EE05085B1 (et) Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks
TR200100769T2 (tr) Yeni bir bileşim
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
DK1355626T3 (da) Veterinær, dermatologisk sammensætning
BRPI0407529A (pt) uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática